Top insider buys and sells from Friday’s market activity
On August 28, 2026, notable insider trading included Optimum Communications (OPTU) director Neil S. Subin buying $2.45M in shares, REGENXBIO (RGNX) director Gregory Austin Ciongoli purchasing $949K, and Pulse Biosciences (PLSE) COO Liane Rae Teplitsky acquiring $99K. United States Antimony (UAMY) CEO Gary C. Evans bought $98K in shares, while Battalion Oil (BATL) director William D. Rogers purchased $91K. On the sell side, Life Time Group (LTH) insiders sold $126M, Relay Therapeutics (RLAY) 10%
How this was made
The 30-second read
Why it matters
Provides traders with direct insight into insider sentiment, which can be a leading indicator for short‑term price moves.
Market read
Insider activity across these tickers may influence short‑term trading decisions, especially for the larger transactions in LTH, RLAY, and SNOW.
What to watch
Potential hidden strategic moves or upcoming financing not disclosed.
Background
The article aggregates recent Form 4 insider transactions across several U.S. listed companies.
Ticker impact
Director Neil S. Subin bought $2.45M of OPTU shares, indicating insider confidence despite a 20% weekly surge.
Modest upside if buying pressure continues.
Insider purchase size relative to float suggests belief in near-term performance.
Director Gregory Austin Ciongoli purchased $949k of RGNX stock, showing belief in the biotech despite a 13% weekly decline.
Limited upside unless broader biotech sentiment improves.
Purchase size modest; market already discounting.
COO Liane Rae Teplitsky bought $99,965 of PLSE shares near its 52‑week high, indicating insider support.
Potential stabilization rather than strong rally.
Purchase small relative to market cap; stock already near peak.
CEO Gary C. Evans bought 20,000 UAMY shares for $98,400, a modest stake increase amid a 46% six‑month decline.
Possible modest upside if market perceives buy‑back support.
Purchase size small; broader commodity exposure dominates.
Director William D. Rogers acquired 70,000 BATL shares for $91,168 while the stock sits near its 52‑week low.
Limited upside unless oil sector improves.
Purchase modest; sector fundamentals weak.
Directors sold roughly $126M of LTH shares at $43.8 each, reflecting significant insider divestment after a 56% annual rally.
Potential short‑term downside.
Sell size large relative to float; could signal concerns.
SVF Pauling (Cayman) Ltd sold 6M RLAY shares for $116.4M after a 426% price surge, indicating profit taking.
Short‑term price pressure expected.
Large block sale after massive rally suggests valuation concerns.
Director Benoit Dageville sold 50,000 SNOW shares for $15.47M under a 10b5‑1 plan, reflecting routine liquidity.
Minimal price effect.
Pre‑arranged plan; market likely priced in.
Market effects
Broad insider activity highlights heightened scrutiny in biotech and energy sectors.
U.S. market participants may adjust exposure to small‑cap biotech and oil stocks.
Limited; primarily affects U.S. listed micro‑cap equities.
Counterpoint
Insider sells may be routine liquidity events, not bearish signals.
Key entities
- DirectorNeil S. Subin
OPTU insider buyer
- DirectorGregory Austin Ciongoli
RGNX insider buyer
- COOLiane Rae Teplitsky
PLSE insider buyer
- CEOGary C. Evans
UAMY insider buyer
- DirectorWilliam D. Rogers
BATL insider buyer
